Trial intelligence / Profile preview

Verapamil vs triamcinolone for hypertrophic scar treatment

IRCT2016010425539N5Phase 2Completed

Sponsor
Iran University of Medical Sciences
Start
Feb 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 2 trial of verapamil and triamcinolone in Hypertrophic Scar (HS) and keloid (2 arms), sponsored by Iran University of Medical Sciences. Started Feb 2016; status: completed.

02

Drugs

verapamiltriamcinolone
03

Conditions

Hypertrophic Scar (HS)keloid

Beyond the preview

Go deeper on IRCT2016010425539N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016010425539N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call